Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study
Infection · 2025-10 · 53 (5) · 1809-1818
DOI: 10.1007/s15010-025-02500-4 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Infection, online erschienen am 11.03.2025. Verfasst von Angela Klingmüller und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department I of Internal Medicine, Division of Infectious Diseases, Medical Faculty and University Hospital Cologne, University of Cologne, Kerpener …. Hauptthemen laut MEDLINE: Antitubercular Agents, Tuberculosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Köln.
Abstract (Originalsprache)
Purpose
Tuberculosis (TB) remains a leading cause of morbidity and mortality, with 1.3 million deaths in 2022. Extrapulmonary tuberculosis (EPTB) accounts for approximately 20% of all TB cases. We assessed the clinical presentation and challenges during the course of treatment in EPTB patients in a low-incidence setting.
Methods
We conducted a prospective cohort study involving 44 EPTB patients at the University Hospital of Cologne, Germany. Clinical data were collected before and during treatment.
Results
The cohort comprised 44 patients originating from 21 countries. Two or more invasive procedures were required for microbiological confirmation in 59% (26/44) of the cases. Sputum culture was positive in 18% (8/44) of patients, with 63% (5/8) showing no radiological signs of pulmonary involvement. The median therapy duration was ten months and increased with disease severity. Paradoxical reactions (PR) occurred in 31% (13/42) of the patients. A previously published clinical scoring system assessing EPTB treatment responses showed a favorable treatment outcome in only 68% (21/31) of the patients in this cohort.
Conclusion
EPTB exhibits highly variable disease severity and organ involvement. Treatment initiation is often delayed due to diagnostic challenges. Management is complicated by the frequent occurrence of PR, which can lead to treatment durations exceeding standard recommendations. Clinical scores for treatment response assessment may not be reliably applicable, highlighting the need for alternative biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department I of Internal Medicine, Division of Infectious Diseases, Medical Faculty and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
- Center for Molecular Medicine Cologne (CMMC), Medical Faculty and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.
- Department of Internal Medicine, Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany.
- Department of Orthopedics and Trauma surgery, Bundeswehr Central Hospital Koblenz, Koblenz, Germany.
- Faculty of Medicine, Institute for Digital Medicine and Clinical Data Science, Goethe University Frankfurt, Frankfurt, Germany.
- German Center for Infection Research (DZIF), Bonn-Cologne, Germany.
Förderung
- Universitätsklinikum Köln
Zitieren
APA
Klingmüller, A., Feldmann, M., Rohr, S., Helmhold, L., Junker, L., Scherer, M., Vehreschild, J. J., Schmidt-Hellerau, K., Hoffmann, A., Jantsch, J., Simonis, A., Suárez, V., Rauschning, D., Funke, N., Malin, J. J., Biehl, L. M., Schommers, P., Fätkenheuer, G., Lehmann, C., …, & Suárez, I. (2025). Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study. Infection, 53(5), 1809-1818. https://doi.org/10.1007/s15010-025-02500-4
Vancouver
Klingmüller A, Feldmann M, Rohr S, Helmhold L, Junker L, Scherer M, et al. Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study. Infection. 2025;53(5):1809-1818. doi:10.1007/s15010-025-02500-4
BibTeX
@article{Klingmller2025,
author = {Klingmüller, Angela and Feldmann, Marie and Rohr, Samuel and Helmhold, Lea and Junker, Lena and Scherer, Margarete and Vehreschild, Jörg-Janne and Schmidt-Hellerau, Kirsten and Hoffmann, Ada and Jantsch, Jonathan and Simonis, Alexander and Suárez, Victor and Rauschning, Dominic and Funke, Natalie and Malin, Jakob J and Biehl, Lena M and Schommers, Philipp and Fätkenheuer, Gerd and Lehmann, Clara and Rybniker, Jan and Suárez, Isabelle},
title = {Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study},
journal = {Infection},
year = {2025},
volume = {53},
number = {5},
pages = {1809--1818},
doi = {10.1007/s15010-025-02500-4}
}
EUVIMED